Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2020

Net Loss Per Share

Schedule of basic and diluted net loss per share

	Three Months Ended				Nine Months Ended
(In thousands, except per share data)	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019
Numerator:
Net loss attributable to CASI Pharmaceuticals, Inc.	$	(16,953)	$	(9,891)	$	(34,088)	$	(33,539)
Denominator:
Weighted average number of common shares		117,940		95,891		105,922		95,753
Denominator for basic and diluted net loss per share calculation		117,940		95,891		105,922		95,753
Net loss per share
— Basic and diluted	$	(0.14)	$	(0.10)	$	(0.32)	$	(0.35)